Physician profile
Rupal S Juran
NPI 1972757581
$5,356.76
in general payments reported to CMS, 2019-2025
24 companies · $278 in 2025
The $278 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $127 · 2020: $326 · 2021: $137 · 2022: $3,650 · 2023: $558 · 2024: $281 · 2025: $278.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,116.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,116.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gen-Probe, INC. | $2,500.00 | 2022 | |
| Gen-Probe Sales & Service, INC. | $794.06 | 2022 | |
| Abbvie INC. | $534.39 | 2019-2025 | |
| Pfizer INC. | $283.74 | 2019-2024 | |
| Ethicon INC. | $242.00 | 2020 | |
| Hologic Sales and Service, LLC | $227.83 | 2023-2025 | Acessa Provu System, Novasure, Coolseal Generator |
| Sumitomo Pharma America, INC. | $171.05 | 2023-2025 | Myfembree, Gemtesa |
| Travere Therapeutics, INC. | $124.99 | 2023 | |
| Gynesonics, INC. | $93.33 | 2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Avion Pharmaceuticals | $66.45 | 2020-2023 | Balcoltra |
| Myovant Sciences INC. | $55.89 | 2021-2022 | |
| Evofem Biosciences, INC. | $37.05 | 2020-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $35.02 | 2023-2025 | |
| Mayne Pharma Commercial LLC | $33.61 | 2022 | |
| Organon LLC | $24.92 | 2022-2025 | Nexplanon |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon US, LLC | $20.96 | 2025 | Dermabond, Ethicon, Surgicel Nu-Knit |
| Axonics, INC. | $18.36 | 2023 | Axonics, Bulkamid |
| Novo Nordisk INC | $15.42 | 2023 | Wegovy |
| Boston Scientific Corporation | $14.92 | 2023 | Solyx Sis System |
| Nevro Corp. | $14.67 | 2019 | |
| Medtronic USA, INC. | $12.62 | 2020 | |
| Therapeuticsmd, INC. | $12.35 | 2020 | |
| Agile Therapeutics, INC. | $12.27 | 2022 | |
| Amag Pharmaceuticals, INC. | $10.86 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rupal Juran listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.